BlackRock HealthBMEZ.NValuation Analysis
Based on the blended 10-year P/E and P/B percentiles, the stock currently sits in the “Richly Valued” zone.
As of Oct 16, 2026, BlackRock Health (BMEZ.N) trades at a P/E of N/A, P/B of 0.94x, P/S of N/A, and a dividend yield of 8.10%.
Longitudinal percentile comparison: P/E historical percentile is still accumulating data over the trailing long-term window (vs. the short-term percentile still accumulating data); P/B sits at the 82nd percentile over the trailing 10Y window (vs. 80th percentile over 3Y); P/S historical percentile is still accumulating data over the trailing long-term window (vs. the short-term percentile still accumulating data).
Cross-sectional valuation: its P/B ranks at the 88th percentile within its industry and the 27th percentile across the broader market.
Shareholder return highlight: Total Shareholder Yield is 62.18%, ranking at the 91st percentile over the trailing 20Y window.
Relative to the broader market, its P/B shows a deeper discount than it does against industry peers. Breaking down the total shareholder yield: 8.10% comes from cash dividends, with an implied ~54.08% from buybacks — a fairly balanced mix of both channels. BlackRock Health operates in the other sector. Data refreshes weekly and is for reference only, not investment advice.
Also listed as: NYSE: BMEZ · BMEZ
Want the full picture on whether BlackRock Health (BMEZ.N) is under- or over-valued? See the full 3Y / 5Y / 10Y / 20Y P/E, P/B, P/S, Dividend Yield & Total Shareholder Yield percentile matrix and the interactive ECharts trend chart on this page.
Historical Percentiles by Metric
| Metric | Current | Market Percentile | Industry Percentile | 3Y Pctl | 5Y Pctl | 10Y Pctl | 20Y Pctl |
|---|---|---|---|---|---|---|---|
| P/E (TTM) | N/A | — | — | — | — | — | — |
| P/B (MRQ) | 0.94 | ||||||
| P/S (TTM) | N/A | — | — | — | — | — | — |
| Dividend Yield | 8.10% | ||||||
| Buyback + Div Yield | 62.18% |